Cargando…

Antioxidant SMe1EC2 modulates pentose phosphate pathway and glutathione-dependent enzyme activities in tissues of aged diabetic rats

The pentose phosphate pathway and glutathione-associated metabolism are the main antioxidant cellular defense systems. This study investigated the effects of the powerful antioxidant SMe1EC2 (2-ethoxycarbonyl-8-methoxy-2,3,4,4a,5,9b-hexahydro-1H-pyrido[4,3-b] indolinium dichloride) on pentose phosph...

Descripción completa

Detalles Bibliográficos
Autores principales: Ulusu, Nuray Nuriye, Gök, Müslüm, Sayin Şakul, Arzu Ayşe, Ari, Nuray, Stefek, Milan, Karasu, Çimen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Slovak Toxicology Society SETOX 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6102677/
https://www.ncbi.nlm.nih.gov/pubmed/30147422
http://dx.doi.org/10.1515/intox-2017-0021
_version_ 1783349218788769792
author Ulusu, Nuray Nuriye
Gök, Müslüm
Sayin Şakul, Arzu Ayşe
Ari, Nuray
Stefek, Milan
Karasu, Çimen
author_facet Ulusu, Nuray Nuriye
Gök, Müslüm
Sayin Şakul, Arzu Ayşe
Ari, Nuray
Stefek, Milan
Karasu, Çimen
author_sort Ulusu, Nuray Nuriye
collection PubMed
description The pentose phosphate pathway and glutathione-associated metabolism are the main antioxidant cellular defense systems. This study investigated the effects of the powerful antioxidant SMe1EC2 (2-ethoxycarbonyl-8-methoxy-2,3,4,4a,5,9b-hexahydro-1H-pyrido[4,3-b] indolinium dichloride) on pentose phosphate pathway (PPP) and glutathione-dependent enzyme activities in aged diabetic and aged matched control rats. Diabetes was induced by streptozotocin injection in rats aged 13–15 months. Diabetic and control rats were divided into two subgroups, one untreated and one treated with SMe1EC2 (10 mg/kg/day, orally) for 4 months. SMe1EC2 ameliorated body weight loss, but not hyperglycemia of aged diabetic rats. Diabetes resulted in decreased glucose-6-phosphate dehydrogenase (G6PD), 6-phosphogluconate dehydrogenase (6PGD) and glutathione-S-transferase (GST), yet in unchanged glutathione reductase (GR) in the liver of aged diabetic rats. In the liver of the aged control rats, SMe1EC2 did not affect G6PDH, 6PGDH and GR, but it inhibited GST. SMe1EC2 also failed to affect diabetes-induced decline in 6PGDH, it ameliorated G6PDH but produced further decline in GST in the liver of aged diabetic rats. In the kidney of aged rats, G6PDH and GST were found to be comparable among the groups, but diabetes up-regulated 6PGDH and GR; these alterations were prevented by SMe1EC2. In the heart of aged diabetic rats, while GST remained unchanged, the recorded increase in G6PD, 6PGD, GR was prevented by SMe1EC2. Furthermore, an unchanged GR and remarkable increases in G6PD, 6PGD and GST were found in the lung of the aged diabetic group. These alterations were completely prevented by SMe1EC2. The results suggest that in aged rats SMe1EC2 can ameliorate the response of the kidney, heart and lung but not that of the liver against diabetes-induced glucotoxicity by interfering with the activity of redox network enzymes.
format Online
Article
Text
id pubmed-6102677
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Slovak Toxicology Society SETOX
record_format MEDLINE/PubMed
spelling pubmed-61026772018-08-24 Antioxidant SMe1EC2 modulates pentose phosphate pathway and glutathione-dependent enzyme activities in tissues of aged diabetic rats Ulusu, Nuray Nuriye Gök, Müslüm Sayin Şakul, Arzu Ayşe Ari, Nuray Stefek, Milan Karasu, Çimen Interdiscip Toxicol Original Article The pentose phosphate pathway and glutathione-associated metabolism are the main antioxidant cellular defense systems. This study investigated the effects of the powerful antioxidant SMe1EC2 (2-ethoxycarbonyl-8-methoxy-2,3,4,4a,5,9b-hexahydro-1H-pyrido[4,3-b] indolinium dichloride) on pentose phosphate pathway (PPP) and glutathione-dependent enzyme activities in aged diabetic and aged matched control rats. Diabetes was induced by streptozotocin injection in rats aged 13–15 months. Diabetic and control rats were divided into two subgroups, one untreated and one treated with SMe1EC2 (10 mg/kg/day, orally) for 4 months. SMe1EC2 ameliorated body weight loss, but not hyperglycemia of aged diabetic rats. Diabetes resulted in decreased glucose-6-phosphate dehydrogenase (G6PD), 6-phosphogluconate dehydrogenase (6PGD) and glutathione-S-transferase (GST), yet in unchanged glutathione reductase (GR) in the liver of aged diabetic rats. In the liver of the aged control rats, SMe1EC2 did not affect G6PDH, 6PGDH and GR, but it inhibited GST. SMe1EC2 also failed to affect diabetes-induced decline in 6PGDH, it ameliorated G6PDH but produced further decline in GST in the liver of aged diabetic rats. In the kidney of aged rats, G6PDH and GST were found to be comparable among the groups, but diabetes up-regulated 6PGDH and GR; these alterations were prevented by SMe1EC2. In the heart of aged diabetic rats, while GST remained unchanged, the recorded increase in G6PD, 6PGD, GR was prevented by SMe1EC2. Furthermore, an unchanged GR and remarkable increases in G6PD, 6PGD and GST were found in the lung of the aged diabetic group. These alterations were completely prevented by SMe1EC2. The results suggest that in aged rats SMe1EC2 can ameliorate the response of the kidney, heart and lung but not that of the liver against diabetes-induced glucotoxicity by interfering with the activity of redox network enzymes. Slovak Toxicology Society SETOX 2017-12 2018-03-01 /pmc/articles/PMC6102677/ /pubmed/30147422 http://dx.doi.org/10.1515/intox-2017-0021 Text en Copyright © 2017 SETOX & Institute of Experimental Pharmacology and Toxicology, SASc. https://creativecommons.org/licenses/by-nc-nd/4.0/ This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License. (CC BY-NC-ND 4.0)
spellingShingle Original Article
Ulusu, Nuray Nuriye
Gök, Müslüm
Sayin Şakul, Arzu Ayşe
Ari, Nuray
Stefek, Milan
Karasu, Çimen
Antioxidant SMe1EC2 modulates pentose phosphate pathway and glutathione-dependent enzyme activities in tissues of aged diabetic rats
title Antioxidant SMe1EC2 modulates pentose phosphate pathway and glutathione-dependent enzyme activities in tissues of aged diabetic rats
title_full Antioxidant SMe1EC2 modulates pentose phosphate pathway and glutathione-dependent enzyme activities in tissues of aged diabetic rats
title_fullStr Antioxidant SMe1EC2 modulates pentose phosphate pathway and glutathione-dependent enzyme activities in tissues of aged diabetic rats
title_full_unstemmed Antioxidant SMe1EC2 modulates pentose phosphate pathway and glutathione-dependent enzyme activities in tissues of aged diabetic rats
title_short Antioxidant SMe1EC2 modulates pentose phosphate pathway and glutathione-dependent enzyme activities in tissues of aged diabetic rats
title_sort antioxidant sme1ec2 modulates pentose phosphate pathway and glutathione-dependent enzyme activities in tissues of aged diabetic rats
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6102677/
https://www.ncbi.nlm.nih.gov/pubmed/30147422
http://dx.doi.org/10.1515/intox-2017-0021
work_keys_str_mv AT ulusunuraynuriye antioxidantsme1ec2modulatespentosephosphatepathwayandglutathionedependentenzymeactivitiesintissuesofageddiabeticrats
AT gokmuslum antioxidantsme1ec2modulatespentosephosphatepathwayandglutathionedependentenzymeactivitiesintissuesofageddiabeticrats
AT sayinsakularzuayse antioxidantsme1ec2modulatespentosephosphatepathwayandglutathionedependentenzymeactivitiesintissuesofageddiabeticrats
AT arinuray antioxidantsme1ec2modulatespentosephosphatepathwayandglutathionedependentenzymeactivitiesintissuesofageddiabeticrats
AT stefekmilan antioxidantsme1ec2modulatespentosephosphatepathwayandglutathionedependentenzymeactivitiesintissuesofageddiabeticrats
AT karasucimen antioxidantsme1ec2modulatespentosephosphatepathwayandglutathionedependentenzymeactivitiesintissuesofageddiabeticrats
AT antioxidantsme1ec2modulatespentosephosphatepathwayandglutathionedependentenzymeactivitiesintissuesofageddiabeticrats